Bio Essence (BIOE) Liabilities from Discontinued Operations (2022 - 2024)
Bio Essence (BIOE) recorded quarterly Liabilities from Discontinued Operations of 1345640.0 in Q1 2024, up 37.75% quarter-over-quarter from 976889.0 in Q4 2023.
Bio Essence (BIOE) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends
Bio Essence's Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 1345640.0 for Q1 2024.
- In Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 1345640.0; the TTM figure through Mar 2024 stood at 1345640.0 (changed N/A YoY), while the FY2023 annual figure was 976889.0, up 18.19% from the prior year.
- Liabilities from Discontinued Operations was 1345640.0 for Q1 2024 at Bio Essence, up from 976889.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 1345640.0 in Q1 2024 to a low of 826537.0 in Q4 2022.
- Historically, Liabilities from Discontinued Operations has averaged 1049688.67 across 3 years, with a median of 976889.0 in 2023.
- Biggest YoY gain for Liabilities from Discontinued Operations was 18.19% in 2023; the steepest drop was 18.19% in 2023.
- A 3-year view of Liabilities from Discontinued Operations shows it stood at 826537.0 in 2022, then advanced by 18.19% to 976889.0 in 2023, then jumped by 37.75% to 1345640.0 in 2024.
- The last three Liabilities from Discontinued Operations figures came in at 1345640.0 (Q1 2024), 976889.0 (Q4 2023), and 826537.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Bio Essence | - | - | 319,353.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 976,889.00 |
| Dec 31, 2023 | 976,889.00 |
| Dec 31, 2022 | 826,537.00 |
| Dec 31, 2022 | 826,537.00 |